Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Susannah Rowles"'
Autor:
Dinesh Kumar Nagi, Susannah Rowles, Andrew Macklin, Umesh Dashora, Heather Oliver, Dipesh Patel
Publikováno v:
British Journal of Diabetes. 21:272-280
Executive Summary A national survey on integrated diabetes services was carried out by the Association of British Clinical Diabetologists (ABCD) during the COVID-19 pandemic and has provided some very useful insights into the current state of integra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b290d3f4fdfa1bbab3e8731518bb285a
https://doi.org/10.15277/bjd.2021.325
https://doi.org/10.15277/bjd.2021.325
Autor:
Anurita Rohilla, Suzanne Phillips, Thomas Sj Crabtree, Alison Evans, Susannah Rowles, Ian W. Gallen, Robert E.J. Ryder, Mahender Yadagiri, Iskandar Idris, Devesh K. Sennik, Alex Bickerton
Publikováno v:
British Journal of Diabetes. 20:19-24
Introduction: People with type 2 diabetes are known to be at increased risk of non-alcoholic fatty liver disease (NAFLD). There is increasing evidence of diabetes treatments with benefits of also improving NAFLD. Although mostly focused on glucagon-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c7e91d464a608155604aac80dd5f3a4
https://doi.org/10.15277/bjd.2020.239
https://doi.org/10.15277/bjd.2020.239
Publikováno v:
British Journal of Diabetes. 22:47-48
We provide a summary on the unprecedented withdrawal of dapagliflozin’s license in Type 1 diabetes by AstraZeneca. We also provide a summary from a national survey of 52 sites in the United Kingdom, with 70% respondents reporting clinically signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fe6230bb5f3e7084206b11dc823b452
https://doi.org/10.15277/bjd.2022.344
https://doi.org/10.15277/bjd.2022.344
Publikováno v:
British Journal of Diabetes. 20:163-165
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd48b07f4da526b230334d54edad3f93
https://doi.org/10.15277/bjd.2020.269
https://doi.org/10.15277/bjd.2020.269
Autor:
Chris Walton, Saiful Kassim, Roy Harper, Paula McDonald, Ursula Brennan, Janet Harding, Thein Htay, Rahul Nayar, Andrew Pernet, Susannah Rowles, Karen Adamson, Ken Y Thong, Robert E J Ryder, On behalf of ABCD Nationwide liraglutide audit contributors
Publikováno v:
British Journal of Diabetes. 20:25-27
Aims: Liraglutide has been shown to reduce cardiovascular mortality in a cardiovascular safety study, but it is not known to what extent these results will be replicated in real practice with people with diabetes treated with liraglutide in the UK. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7b6a018224f9ed3824062b9b2d8afc9
https://doi.org/10.15277/bjd.2020.243
https://doi.org/10.15277/bjd.2020.243
Autor:
Thomas SJ Crabtree, Susannah Rowles, Stephanie Tarpey, Adele Kennedy, John Chalmers, Rahul Nayar, Amanda Lee, Ken Darzy, Peter Winocour, John Lindsay, Iskandar Idris, Ken Y Thong, Piya Sen Gupta, Amar Puttanna, Pranav Kumar, Robert EJ Ryder, On Behalf of ABCD Nationwide Audit Contributors
Publikováno v:
British Journal of Diabetes. 19:118-123
People with type 2 diabetes mellitus experience an increased prevalence of non-alcoholic fatty liver disease (NAFLD) compared with the general population and often with worse outcomes. As part of the ABCD Liraglutide Nationwide Audit Programme, we ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86698fc49f7ca34ddca029b8202e527a
https://doi.org/10.15277/bjd.2019.227
https://doi.org/10.15277/bjd.2019.227
Autor:
Susannah Rowles, Rebecca Reeve, Alistair Lumb, Umesh Dashora, Pratik Choudhury, Andrew Macklin, Dinesh Nagi, Tim Robbins, Dipesh Patel
Publikováno v:
British Journal of Diabetes. 19:156-161
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87e55e51d5237e1ca83e8251b2e75b26
https://doi.org/10.15277/bjd.2019.235
https://doi.org/10.15277/bjd.2019.235
Autor:
Ketan Dhatariya, Gerry Rayman, Parijat De, Robert Gregory, Susannah Rowles, Umesh Dashora, Diabetes Uk, Katie Whitehead, Dipesh C Patel, Andrew Macklin, Peter H. Winocour, Dinesh Nagi, Hannah Beba
Publikováno v:
Clin Med (Lond)
Sodium glucose co-transporter 2 (SGLT2) inhibitors are now an established class of medications for the treatment of type 2 diabetes (T2D), no longer reserved for use by specialists in diabetes. They are being used increasingly for their cardiac and r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5c22e4dfaa03f79aea79661123bc935
https://europepmc.org/articles/PMC8140708/
https://europepmc.org/articles/PMC8140708/
Autor:
Robert Gregory, Andrew Macklin, Umesh Dashora, Gerry Rayman, Susannah Rowles, Dinesh Nagi, Ketan Dhatariya, Peter H. Winocour, Dipesh C Patel
Publikováno v:
Diabetic medicine : a journal of the British Diabetic AssociationREFERENCES. 38(2)
Dapagliflozin (sodium-glucose co-transporter (SGLT-2) inhibitor) and sotagliflozin (SGLT-1/2 inhibitor) are two of the drugs of the SGLT inhibitor class which have been recommended by the National Institute for Health and Care Excellence (NICE) in pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c2cb9c0c10367af7fa7d26d55ca9ff
https://pubmed.ncbi.nlm.nih.gov/33179277
https://pubmed.ncbi.nlm.nih.gov/33179277
Autor:
Ketan Dhatariya, R E J Ryder, Bob Ryder, Susannah Rowles, John A. McKnight, John McKnight Bao
Publikováno v:
Practical Diabetes. 30:388-391
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cb5cc6930297c2603db0f7d74ab9e4c
https://doi.org/10.1002/pdi.1816
https://doi.org/10.1002/pdi.1816